Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANTIUI Protocol in Unexplained Infertility
NCT04754243Phase 4Unknown
- Sponsor
- Tanta University
- Start
- Mar 2021
- Primary completion
- Dec 2024
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cetrorelix in Unexplained infertility, sponsored by Tanta University. Status: unknown.
02
Drugs
cetrorelix
03
Conditions
Unexplained infertility
Beyond the preview
Go deeper on NCT04754243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04754243.